Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

TIFFANY A TRAINA

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1730285990
CMS profile
124403
Location
NEW YORK, NY

General Payments · PY2018–2024

$316,559.76

  • Reported across 197 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$39,415.62

24 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $32,757.50 16
Travel and Lodging $5,832.54 1
Food and Beverage $753.83 6
Honoraria $71.75 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Gilead Sciences, Inc. $8,862.54 3
AstraZeneca UK Limited $8,317.50 6
Stemline Therapeutics Inc. $8,127.40 8
Acerta Pharma LLC $5,615.00 3
BioNTech SE $4,725.00 1
NOVARTIS PHARMACEUTICALS CORPORATION $2,778.18 2
Genentech, Inc. $990.00 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $59,816.30 50
PY2019 $63,819.89 34
PY2020 $37,527.82 29
PY2021 $34,221.92 14
PY2022 $51,745.08 30
PY2023 $30,013.13 16
PY2024 $39,415.62 24

Payment records · PY2024 (24)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $135.00 06/02/2024 Food and Beverage Undisputed 01/23/2026 1105821013 CMS
AstraZeneca Pharmaceuticals LP $4,110.00 10/23/2024 Consulting Fee Undisputed 01/23/2026 1104372755 CMS
AstraZeneca Pharmaceuticals LP $1,370.00 12/23/2024 Consulting Fee Undisputed 01/23/2026 1105207485 CMS
AstraZeneca UK Limited $3,082.50 02/07/2024 Consulting Fee Undisputed 01/23/2026 1093936817 CMS
AstraZeneca UK Limited $35.00 06/01/2024 Food and Beverage Undisputed 01/23/2026 1094036261 CMS
AstraZeneca UK Limited $685.00 07/09/2024 Consulting Fee Undisputed 01/23/2026 1093908383 CMS
AstraZeneca UK Limited $1,370.00 09/12/2024 Consulting Fee Undisputed 01/23/2026 1094021912 CMS
AstraZeneca UK Limited $2,460.00 11/20/2024 Consulting Fee Undisputed 01/23/2026 1093988790 CMS
AstraZeneca UK Limited $685.00 12/02/2024 Consulting Fee Undisputed 01/23/2026 1093946090 CMS
BioNTech SE $4,725.00 12/19/2024 Consulting Fee Undisputed 01/23/2026 1150660536 CMS
Genentech, Inc. $990.00 05/08/2024 Consulting Fee Undisputed 01/23/2026 1133125308 CMS
Gilead Sciences, Inc. $5,832.54 10/24/2024 Travel and Lodging Undisputed 01/23/2026 1133870128 CMS
Gilead Sciences, Inc. $150.00 12/12/2024 Food and Beverage Undisputed 01/23/2026 1133829223 CMS
Gilead Sciences, Inc. $2,880.00 12/18/2024 Consulting Fee Undisputed 01/23/2026 1133600029 CMS
Novartis Pharmaceuticals Corporation $178.18 12/10/2024 Food and Beverage Undisputed 01/23/2026 1087442122 CMS
Novartis Pharmaceuticals Corporation $2,600.00 12/10/2024 Consulting Fee Undisputed 01/23/2026 1087442126 CMS
Stemline Therapeutics Inc. $1,950.00 02/02/2024 Consulting Fee Undisputed 01/23/2026 1142965213 CMS
Stemline Therapeutics Inc. $390.00 04/12/2024 Consulting Fee Undisputed 01/23/2026 1142965217 CMS
Stemline Therapeutics Inc. $137.72 05/30/2024 Food and Beverage Undisputed 01/23/2026 1142965227 CMS
Stemline Therapeutics Inc. $2,340.00 06/28/2024 Consulting Fee Undisputed 01/23/2026 1142965231 CMS
Stemline Therapeutics Inc. $2,340.00 06/28/2024 Consulting Fee Undisputed 01/23/2026 1142965238 CMS
Stemline Therapeutics Inc. $71.75 07/12/2024 Honoraria Undisputed 01/23/2026 1142965223 CMS
Stemline Therapeutics Inc. $117.93 12/09/2024 Food and Beverage Undisputed 01/23/2026 1142965234 CMS
Stemline Therapeutics Inc. $780.00 12/20/2024 Consulting Fee Undisputed 01/23/2026 1142965240 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.